Medtronic Announces FDA Approval Of SenSight Directional Lead System For Treating Movement Disorders

Medtronic said it will launch the SenSight DBS in the US after winning FDA approval. The total DBS market is expected to exceed $1bn by 2024, according to Meddevicetracker.